Metagenomi Therapeutics, Inc. logo

Metagenomi Therapeutics, Inc.

MGX • NASDAQ • Stock Fundamentals

Metagenomi Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jian Irish, with a market cap of $51.2M.

Market Cap$51.2M
Employees236.0
CEOJian Irish
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 11, 2026 · 17 days agoQ1 2026
View report
Next EarningsAug 11, 2026 · in 2 monthsBefore Market Open · Q2 2026
Income StatementBalance SheetCash FlowSegments

Financials

Based on Q1 2026 filing

View all metrics
Metagenomi Therapeutics, Inc. logo

Metagenomi Therapeutics, Inc. FAQ

Common questions about Metagenomi Therapeutics, Inc.

Metagenomi Therapeutics, Inc. (MGX) has a market capitalization of $51.2M and trades on NASDAQ.

Metagenomi Therapeutics, Inc. has approximately 236 employees.